Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects)

Antimicrobial therapy of community-acquired pneumonia in a hospital setting (clinical and economic aspects)

The aim is to study the clinical and economic components of antimicrobial therapy (AMT) of community-acquired pneumonia (CAP) in a hospital ptactice.Materials and methods. Case reports of 48 patients with CAP hospitalized in FBU PMLC FMBA in the city of Nizhny Novgorod during 2016 were studied. All...

Full description

Bibliographic Details
Main Authors:	O. V. Zhukova, O. V. Ruina, M. V. Khazov, S. V. Romanov
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2018-05-01
Series:	Фармакоэкономика
Subjects:	community-acquired pneumonia antimicrobial therapy treatment standards the frequency of antimicrobial use the economic component of antimicrobial therapy
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/228

Similar Items

Analysis of the efficiency of antimicrobial treatment for community-acquired pneumonia in clinical practice
by: O V Zhukova, et al.
Published: (2017-08-01)

Community-acquired pneumonia. Clinical recommendations. Yesterday, today and tomorrow. To the article (round-table discussion: physician, pulmonologist, clinical pharmacologist)
by: Leonid I. Dvoretsky, et al.
Published: (2019-03-01)

HOW LONG SHOULD THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA CONTINUE? FOCUS ON SHORT-COURSE ANTIMICROBIAL THERAPY
by: A. A. Zaitsev, et al.
Published: (2017-07-01)

Empiric antibiotic therapy in the treatment of community-acquired pneumonia in a general hospital in Saudi Arabia
by: Jaffar A Al-Tawfiq, et al.
Published: (2019-01-01)

Comparative analysis of antimicrobial drugs recommended by medical and technological documents for the treatment of patients with community-acquired pneumonia
by: L. V. Iakovlieva, et al.
Published: (2019-05-01)

Community-acquired pneumonia in hospitalized patients: clinical guidelines
by: A. A. Zaytsev, et al.
Published: (2019-12-01)

Nasopharyngeal bacterial carriage and antimicrobial resistance in underfive children with community acquired pneumonia
by: Cissy B. Kartasasmita, et al.
Published: (2001-12-01)

Clinical characteristics and outcomes of community-acquired pneumonia in western Saudi Arabia: A four-year retrospective analysis of medical records
by: Fayssal M. Farahat, et al.
Published: (2021-07-01)

Outcomes of Stenotrophomonas maltophilia hospital-acquired pneumonia in intensive care unit: a nationwide retrospective study
by: Philippe Guerci, et al.
Published: (2019-11-01)

An audit of community-acquired pneumonia antimicrobial compliance using an intervention bundle in an Irish hospital
by: Brendan O’Kelly, et al.
Published: (2020-12-01)

CLINICAL CHARACTERISTICS OF MYCOPLASMA PNEUMONIA IN HOSPITALIZED PATIENTS
by: L. I. Zhukova, et al.
Published: (2018-12-01)

A trend in prevalence of antimicrobial use and appropriateness of antimicrobial therapy in an acute care hospital from 2018 to 2019: repeated prevalence surveys in Japan
by: Junpei Komagamine, et al.
Published: (2019-12-01)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
by: Mariana Lopes, et al.
Published: (2021-01-01)

Antimicrobial-Drug Use and Changes in Resistance in Streptococcus pneumoniae
by: Daniel J. Diekema, et al.
Published: (2000-10-01)

Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
by: Sellarès-Nadal J, et al.
Published: (2020-11-01)

Selective digestive decontamination and empirical antimicrobial therapy of late–onset ventilator–associated pneumonia in trauma patients
by: Frédéric Garcin, et al.
Published: (2012-01-01)

Community-acquired bacterial pneumonia in adults: An update
by: Vandana Kalwaje Eshwara, et al.
Published: (2020-01-01)

Cost differentials between private and public hospitals for antimicrobial treatment of admitted patients suffering from pneumonia and diarrhoea
by: Seikh Farid Uddin Akter, et al.
Published: (2008-07-01)

Cost Effectiveness of Different Initial Antimicrobial Regimens for Elderly Community-Acquired Pneumonia Patients in General Ward
by: Han X, et al.
Published: (2021-05-01)

Clinical characteristics, antimicrobial resistance and capsular types of community-acquired, healthcare-associated, and nosocomial Klebsiella pneumoniae bacteremia
by: Chih-Han Juan, et al.
Published: (2019-01-01)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01)

Modern approaches to the rational choice of antibiotic for treatment of community-acquired pneumonia in various categories of patients
by: S. K. Zyryanov, et al.
Published: (2019-08-01)

Community-acquired pneumonia in the United Kingdom: a call to action
by: James Chalmers, et al.
Published: (2017-10-01)

The choice of antibiotic for community-acquired pneumonia – the results of a survey of doctors and an analysis of real outpatient practice
by: V. G. Deriushkin, et al.
Published: (2020-04-01)

Community acquired pneumonia among pediatric outpatients in Salvador, Northeast Brazil, with emphasis on the role of pneumococcus
by: Nascimento-Carvalho Cristiana M.C., et al.
Published: (2001-01-01)

Community acquired pneumonia among pediatric outpatients in Salvador, Northeast Brazil, with emphasis on the role of pneumococcus
by: Cristiana M.C. Nascimento-Carvalho, et al.

Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: A multi-center study in Taiwan
by: Chieh-Liang Wu, et al.
Published: (2013-01-01)

Antimicrobial susceptibility of Streptococcus pneumoniae in Kazakhstan
by: Azyzov I.S., et al.
Published: (2019-10-01)

Influence of severity of infection on the effect of appropriate antimicrobial therapy for Acinetobacter baumannii bacteremic pneumonia
by: Fang-Yu Kang, et al.
Published: (2020-09-01)

LEUKOCYTES LIPID RELEASE ABILITY AND CERTAIN IMMUNE DEFICIENCY CRITERIA IN COMMUNITY ACQUIRED PNEUMONIAE PATIENTS
by: V. Ju. Mishlanov, et al.
Published: (2014-07-01)

Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China
by: Tingting Le, et al.
Published: (2021-02-01)

Community-acquired pneumonia
by: Milutinović-Matić Snežana R., et al.
Published: (2018-01-01)

Antimicrobial Resistant Streptococcus pneumoniae Infections: Clinical and Epidemiological Trends
by: James Kellner, et al.
Published: (2020-12-01)

Antimicrobial Resistance in Streptococcus pneumoniae, Taiwan
by: Po-Ren Hsueh, et al.
Published: (2002-12-01)

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia
by: Nathan Peiffer-Smadja, et al.
Published: (2020-06-01)

COVID19 pandemic is a «pandemic» of antimicrobial therapy
by: Sinopalnikov A.I.
Published: (2021-04-01)

Antimicrobial resistance of clinical Streptococcus pneumoniae isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»
by: Ivanchik N.V., et al.
Published: (2019-12-01)

The Relationship between Antimicrobial Use and Antimicrobial Resistance in Europe
by: Stef L.A.M. Bronzwaer, et al.
Published: (2002-03-01)

Assessment of Appropriateness of Antimicrobial Therapy in Resource-Constrained Settings: Development and Piloting of a Novel Tool—AmRAT
by: Ashish Kumar Kakkar, et al.
Published: (2021-02-01)

Nontyphoid Salmonella Infection: Microbiology, Clinical Features, and Antimicrobial Therapy
by: Hung-Ming Chen, et al.
Published: (2013-06-01)